Systematic Review
Published on 29 Mar 2023
Comparative cardiotoxicity risk of pembrolizumab versus nivolumab in cancer patients undergoing immune checkpoint inhibitor therapy: A meta-analysis
in Cardio-Oncology
- 4,713 views
- 4 citations
Systematic Review
Published on 29 Mar 2023
in Cardio-Oncology
Clinical Trial
Published on 21 Mar 2023
in Cardio-Oncology
Original Research
Published on 10 Mar 2023
in Cardio-Oncology
Original Research
Published on 08 Feb 2023
in Cardio-Oncology
Original Research
Published on 01 Feb 2023
in Cardio-Oncology
Original Research
Published on 24 Jan 2023
in Cardio-Oncology
Case Report
Published on 07 Dec 2022
in Cardio-Oncology
Systematic Review
Published on 09 Nov 2022
in Cardio-Oncology
Case Report
Published on 27 Oct 2022
in Cardio-Oncology
Original Research
Published on 14 Oct 2022
in Cardio-Oncology
Original Research
Published on 10 Oct 2022
in Cardio-Oncology
Original Research
Published on 03 Oct 2022
in Cardio-Oncology
Case Report
Published on 23 Sep 2022
in Cardio-Oncology
Original Research
Published on 20 Sep 2022
in Cardio-Oncology
Original Research
Published on 15 Sep 2022
in Cardio-Oncology
Original Research
Published on 12 Sep 2022
in Cardio-Oncology